Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03861819 · ClinicalTrials.gov registry record · NA
Feasibility of VIIT in Adults With NASH
A NA study of Liver Diseases and Nonalcoholic Steatohepatitis, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT03861819: Completed NA study of Liver Diseases and Nonalcoholic Steatohepatitis, sponsored by Duke University.
NCT03861819 is a NA study of Liver Diseases and Nonalcoholic Steatohepatitis that has completed, run by Duke University. The registered enrollment target is 24 participants, below the 61,158-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03861819, a NA study of Liver Diseases and Nonalcoholic Steatohepatitis, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether patients with stage 1-3 NASH-related fibrosis are able to complete a single vigorous-intensity interval training (VIIT) session on an indoor rowing machine and provide blood samples before and afterwards. The results of this study will provide the foundation for future research on the role of VIIT in treating NASH.
Primary Outcome
This study is designed to assess the feasibility of a VIIT intervention for adults with NASH-related fibrosis. Adherence will be measured as the % of subjects who are able to achieve the protocol target of 80% of their max heart rate during the intervention.
Conditions Studied
Interventions
- BEHAVIORAL Vigorous-intensity interval training (VIIT)
Study Locations (1)
North Carolina
- Duke Integrative Medicine - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2018-12-07 |
| Phase | NA |
What the finished NCT03861819 record still lists
NCT03861819 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 61,158-participant average among 33 other Liver Diseases trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Liver Diseases appearing as the primary indexed condition, and to 1 intervention - of which Vigorous-intensity interval training (VIIT) is the first listed.
NCT03861819 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03861819 about?
NCT03861819 is a clinical study titled "Feasibility of VIIT in Adults With NASH". The purpose of this study is to determine whether patients with stage 1-3 NASH-related fibrosis are able to complete a single vigorous-intensity interval training (VIIT) session on an indoor rowing machine and provide blood samples before and afterwards. The results of this study will provide the fo...
What is the current status of trial NCT03861819?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-01-01. Estimated completion is 2018-12-07.
What conditions does trial NCT03861819 study?
This clinical trial studies the following conditions: Liver Diseases, Nonalcoholic Steatohepatitis, Non-alcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver.
What interventions are being tested in trial NCT03861819?
The interventions under investigation include: Vigorous-intensity interval training (VIIT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03861819?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03861819 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03861819's enrollment target sits among peer trials
24 32nd of 33 higher than 1 of 33 other Liver Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
RECRUITING · NA
-
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
RECRUITING · NA
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
-
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
RECRUITING · NA
-
Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement
RECRUITING · NA
-
Liver Cancer Prevention Randomized Control Trial
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI